CXCL10 and COVID-19: In the present study, the increase in IP-10 and MIG levels in stage 2 COVID-19 patients could point to immune system activation and a stronger inflammatory response, which increases the risk of serious complications (organ failure) in stage 2 than in stage 1 patients.